Accueil
Détail de l'auteur
Auteur L. PLATT |
Documents disponibles écrits par cet auteur (13)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]Article : Périodique
L. PLATT ; T. RHODES ; A. JUDD ; E. KOSHKINA ; MAKSIMOVA S. ; N. LATISHEVSKAYA ; A. RENTON ; T. McDONALD ; J. V. PARRY |ENGLISH : OBJECTIVES: We examined risk factors for syphilis infection among injection drug users in 3 Russian Federation cities, focusing particular attention on the potential roles of gender and sex work. METHODS: We conducted a cross-section[...]Article : Périodique
S. SWEENEY ; Z. WARD ; L. PLATT ; L. GUINNESS ; M. HICKMAN ; V. HOPE ; L. MAHER ; J. IVERSEN ; S. J. HUTCHINSON ; J. SMITH ; R. AYRES ; I. HAINEY ; P. VICKERMAN |AIM: To evaluate the cost-effectiveness of needle and syringe programmes (NSPs) compared with no NSPs on hepatitis C virus (HCV) transmission in the United Kingdom. DESIGN: Cost-effectiveness analysis from a National Health Service (NHS)/healt[...]Article : Périodique
L. PLATT ; G. J. MELENDEZ-TORRES ; A. O'DONNELL ; J. BRADLEY ; D. NEWBURY-BIRCH ; E. KANER ; C. ASHTON |Background: While the efficacy and effectiveness of brief interventions for alcohol (ABI) have been demonstrated in primary care, there is weaker evidence in other settings and reviews do not consider differences in content. We conducted a syste[...]Article : Périodique
A. LATYPOV ; J. P. GRUND ; N. EL-BASSEL ; L. PLATT ; H. STÖVER ; S. STRATHDEE |In 2013, two special issues with focus on health and drugs in Central Asia were published in Drug and Alcohol Dependence and Central Asian Survey journals ( El-Bassel et al., 2013a, Latypov, 2013 and Latypov, 2014). In this third special issue p[...]Article : Périodique
Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN |Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]Périodique
L. PLATT ; M. WALL ; T. RHODES ; A. JUDD ; M. HICKMAN ; L. JOHNSTON ; A. RENTON ; N. BOBROVA ; SARANG A. | 2006ENGLISH : Evidence suggests rapid diffusion of injecting drug use and associated outbreaks of HIV among injecting drug users (IDUs) in the Russian Federation and Eastern Europe. There remains a need for research among non-treatment and communi[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
L. PLATT ; P. EASTERBROOK ; E. GOWER ; B. MCDONALD ; K. SABIN ; C. McGOWAN ; I. YANNY ; H. RAZAVI ; P. VICKERMAN |Background: At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV-HCV co-infection. We sought to characterise the epidemiology an[...]Périodique
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study
T. RHODES ; L. PLATT ; S. MAXIMOVA ; E. KOSHKINA ; N. LATISHEVSKAYA ; M. HICKMAN ; A. RENTON ; N. BOBROVA ; T. McDONALD ; J. V. PARRY | 2006Objectives: To estimate the prevalence of HIV, hepatitis C virus (HCV) and syphilis in injecting drug users (IDUs) in Russia. Methods: Unlinked anonymous cross-sectional survey of 1473 IDUs recruited from non-treatment settings in Moscow, Volgog[...]Article : Périodique
A. TALU ; Rajaleid K ; K. ABEL-OLLO ; K. RÜÜTEL ; Rahu M ; T. RHODES ; L. PLATT ; Bobrova N ; A. UUSKULA |BACKGROUND: Following a heroin shortage, fentanyl and 3-methylfentanyl, known as "China White" and "White Persian", have become the most widely used drugs, along with amphetamine, among injecting drug users (IDUs) in Tallinn, Estonia. METHODS: I[...]Périodique
The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage
L. PLATT ; M. HICKMAN ; T. RHODES ; MIKHAILOVA L. ; KARAVASHKIN V. ; VLASOV A. ; K. TILLING ; V. HOPE ; KHUTORKSOY M. ; A. RENTON | 2004FRANÇAIS : L'étude a été menée à partir de 3 sources de données : les dossiers des services de soins, les statistiques policières et les données sur la séropositivité. La population des usagers de drogues injectables est estimée à 20 226 person[...]